⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30839213 | 1.00 | — | — | |
| SCHEMBL3190050 | 0.79 | — | — | |
| SCHEMBL30982621 | 0.79 | — | — | |
| SCHEMBL9670289 | 0.79 | — | — | |
| SCHEMBL14803298 | 0.77 | TRPA1 (0.33) | — | |
| SCHEMBL11980565 | 0.75 | — | — | |
| SCHEMBL8964040 | 0.75 | — | — | |
| SCHEMBL6386890 | 0.75 | — | — | |
| SCHEMBL20601016 | 0.75 | — | — | |
| SCHEMBL19899743 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115028576-B | Production process of 3, 5-dichloro-2, 6-dimethyl-4-hydroxypyridine | 广西金源生物化工实业有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-115028576-A | Production process of 3, 5-dichloro-2, 6-dimethyl-4-hydroxypyridine | 广西金源生物化工实业有限公司 | 2022-09-09 | — | — | CN | claimed |
| WO-2004024151-A1 | COMPOSITION AND POTENTIATING METHOD | NEW PHARMA RESEARCH SWEDEN AB (SE) | 2004-03-25 | — | — | WO | claimed |
| US-20250101013-A1 | FUNCTIONALIZED AMINOTHIAZOLES | LEADXPRO AG (CH) | 2025-03-27 | — | — | US | disclosed |
| EP-4466267-A1 | FUNCTIONALIZED AMINOTHIAZOLES | LeadXpro AG (CH) | 2024-11-27 | — | — | EP | disclosed |
| CN-118574828-A | Functionalized aminothiazoles | 里德埃克斯普洛股份公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-115028576-B | Production process of 3, 5-dichloro-2, 6-dimethyl-4-hydroxypyridine | 广西金源生物化工实业有限公司 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023220741-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023139132-A1 | FUNCTIONALIZED AMINOTHIAZOLES | LEADXPRO AG (CH) | 2023-07-27 | — | — | WO | disclosed |
| CN-115028576-A | Production process of 3, 5-dichloro-2, 6-dimethyl-4-hydroxypyridine | 广西金源生物化工实业有限公司 | 2022-09-09 | — | — | CN | disclosed |
| EP-3528808-B1 | METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS | BIOSPLICE THERAPEUTICS INC (US) | 2021-10-06 | — | — | EP | disclosed |
| EP-1784403-A1 | PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Yuhan Corporation (KR) | 2007-05-16 | — | — | EP | disclosed |
| CN-1882589-A | Novel heterocyclic compounds as HSP 90-inhibitors | CONFORMA THERAPEUTICS CORP (US) | 2006-12-20 | — | — | CN | disclosed |
| WO-2006038773-A1 | PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | YUHAN CORPORATION (KR) | 2006-04-13 | — | — | WO | disclosed |
| CN-1735599-A | 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands | BOEHRINGER INGELHEIM PHARMA (US) | 2006-02-15 | — | — | CN | disclosed |
| EP-0974602-B1 | Catalyst and process for hydrogenating olefinically unsaturated compound | JSR CORP (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-6291596-B1 | CONTACTING OLEFINICALLY UNSATURATED COMPOUND WITH HYDROGEN IN THE PRESENCE OF A HYDROGENATION CATALYST COMPRISING TITANIUM OR ZIRCONIUM OR HAFNIUM COMPOUND IN AN INERT, ORGANIC SOLVENT | JSR CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-0974602-A1 | Catalyst and process for hydrogenating olefinically unsaturated compound | JSR Corporation (JP) | 2000-01-26 | — | — | EP | disclosed |
| US-5322852-A | Antitumor, antiprotozoa agents | CIBA-GEIGY CORP. (US) | 1994-06-21 | — | — | US | disclosed |
| EP-0558443-A1 | O-Piperidyl-(3/4)-hydroxylamines and O-piperidyl-(3/4)-alkyl-hydroxylamines and their use as ornithine decarboxylase inhibitors | CIBA-GEIGY AG (CH) | 1993-09-01 | — | — | EP | disclosed |